Reedland Capital Partners - Representative Transactions

Representative Transactions - A Measure of Our Success

Since 1998, Reedland Capital Partners has successfully arranged over $2 billion in financings for companies located all over the United States and Canada in over a dozen different industries, including: technology, healthcare, IT solutions, manufacturing, distribution, retail, gaming, lodging and entertainment.

Following is a sampling of transactions that Reedland Capital Partners has arranged for clients by industry:
A complete list of transactions is available from this password-protected link. To obtain a password, contact the site administrator.


DATE	INDUSTRY	VALUE	TRANSACTION TYPE
November 2011	Pharmaceuticals	$50,000,000*	Committed Equity Facility
August 2011	Technology	$50,000,000*	Committed Equity Facility
May 2011	REIT	$40,000,000*	Committed Equity Facility
November 2010	Technology	$35,000,000	Revolving Credit Facility
October 2010	Biopharmaceuticals	$35,000,000*	Committed Equity Facility
August 2010	Technology	$60,000,000*	Committed Equity Facility
August 2010	REIT	$100,000,000*	Committed Equity Facility
July 2010	Pharmaceuticals	$50,000,000*	Committed Equity Facility
July 2010	Biopharmaceuticals	$40,000,000*	Committed Equity Facility
July 2010	Biotechnology	$20,000,000*	Committed Equity Facility
June 2010	Beverages	$10,000,000*	Committed Equity Facility
June 2010	Healthcare	$15,000,000*	Committed Equity Facility
May 2010	Biopharmaceuticals	$25,000,000*	Committed Equity Facility
January 2010	Biopharmaceuticals	$25,000,000*	Committed Equity Facility
November 2009	Biopharmaceuticals	$60,000,000*	Committed Equity Facility
October 2009	Biotechnology	$35,000,000	Equity
October 2009	Technology	$25,000,000*	Committed Equity Facility
October 2009	Biotechnology	$35,000,000	Equity
September 2009	Biopharmaceuticals	$60,000,000*	Managed Equity Facility
August 2009	Biopharmaceuticals	$40,000,000*	Committed Equity Facility
August 2009	Biopharmaceuticals	$60,000,000*	Committed Equity Facility
October 2008	Biotechnology	$50,000,000*	Committed Equity Facility
October 2008	Biopharmaceuticals	$60,000,000*	Committed Equity Facility
July 2008	Biotechnology	$192,000,000	Co-Advisor to Company Under Acquisition
March 2008	Biopharmaceuticals	$50,000,000*	Committed Equity Facility (2008)
July 2007	Biotechnology	$54,000,000‡	Sale of Company
October 2007	Biotechnology	$130,000,000*	Committed Equity Facility
September 2007	Biotechnology	$100,000,000*	Committed Equity Facility
May 2007	Hospitality/Hotels	$100,000,000	Senior Mortgage
May 2007	Hospitality/Hotels	$27,000,000	Mezzanine Financing
February 2007	Biotechnology	$50,000,000*	Committed Equity Facility
December 2006	Pharmaceuticals	$30,000,000*	Committed Equity Facility
October 2006	Pharmaceuticals	$75,000,000*	Committed Equity Facility
September 2006	Pharmaceuticals	$150,000,000*	Committed Equity Facility
September 2006	Biotechnology	$75,000,000*	Committed Equity Facility
June 2006	Pharmaceuticals	$75,000,000*	Committed Equity Facility
June 2006	Biotechnology	$75,000,000*	Committed Equity Facility
June 2006	Healthcare	$3,000,000	Equity
April 2006	Biotechnology	$200,000,000*	Committed Equity Facility
December 2005	Technology	$6,500,000	Venture Debt Facility
August 2005	Healthcare	$32,000,000	Equity
July 2005	Pharmaceuticals	$77,000,000	Equity
July 2005	Pharmaceuticals	$56,000,000	Senior Debt Facility
April 2004	Tobacco	$13,000,000	Equity
February 2004	Biotechnology	$25,000,000	Equity
February 2004	Biotechnology	$237,000,000	Committed Equity Facility
February 2004	Biotechnology	$6,200,000	Equity
October 2003	Mobile Homes/RVs	$20,000,000	Equity
September 2003	Pharmaceuticals	$115,000,000	Equity (Series D)
June 2000	Technology	$191,000,000	Equity

Amount reflects overall purchase commitment(s) facilitated by Reedland and not necessarily the total amount of securities that will be sold pursuant to applicable purchase agreements. * Facilitated via third party. ^‡ Amount inclusive of up to an additional $12MM in 2009 contingent payments and product royalties.